2 recruiting, 1 completed. 3 Early Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Early Phase 1 | 3 | Recruiting 2, Completed 1 |
Follow Gastric Outlet Obstruction: new trials by email Literature Review of Gastric Outlet Obstruction trials Research Report on Gastric Outlet Obstruction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Pilot Study of IT Topotecan and Maintenance Chemotherapy for HR-EBTs in Children < 6 Years, Post Consolidation Cytarabine IT, hydrocortisone, Cisplatin - CNS Embryonal Tumor, CNS, Medulloblastoma | Early Phase 1 | Recruiting | C17 Council | 15 | 2025-09-23 | 2026-07-14 |
| Iomab-ACT: A Pilot Study of 131-I Apamistamab Followed by CD19-Targeted CAR T-Cell Therapy for Patients With Relapsed or Refractory B-Cell Acute Lymphoblastic Leukemia or Diffuse Large B-Cell Lymphoma 131-I Apamistamab, CAR T-cell - B-ALL, DLBCL | Early Phase 1 | Recruiting | Memorial Sloan Kettering Cancer Center | 12 | 2021-02-02 | 2026-02-17 |
| Post-Operative Impact of Nasogastric Tubes on Rates of Emesis in Infants Diagnosed With Pyloric Stenosis Nasogastric Tube - Pyloric Stenosis | Early Phase 1 | Completed | Hamilton Health Sciences Corporation | 50 | 2010-01-01 | 2015-09-28 |
Pyloric Stenosis, Hypertrophic (2) · Lymphoma, Large B-Cell, Diffuse (1) · Medulloblastoma (1) · Neuroblastoma (1) · Neuroectodermal Tumors, Primitive (1) · Pinealoma (1) · Pyloric Stenosis (1) · Rhabdoid Tumor (1)
Digestive System Diseases (3) · Gastrointestinal Diseases (3) · Stomach Diseases (3) · Neoplasms (2) · Neoplasms by Histologic Type (2) · Pyloric Stenosis (2) · Brain Diseases (1) · Brain Neoplasms (1) · Central Nervous System Diseases (1) · Central Nervous System Neoplasms (1) · Glioma (1) · Hemic and Lymphatic Diseases (1) · Immune System Diseases (1) · Immunoproliferative Disorders (1)
Carboplatin (1) · Celecoxib (1) · Cisplatin (1) · Cyclophosphamide (1) · Enteral Nutrition (1) · Etoposide (1) · Filgrastim (1) · Granulocyte Colony-Stimulating Factor (1) · Hydrocortisone (1) · Immunotherapy, Adoptive (1) · Isotretinoin (1) · Mesna (1) · Tamoxifen (1) · Temozolomide (1) · Thiotepa (1)
C17 Council (1) · Hamilton Health Sciences Corporation (1) · Memorial Sloan Kettering Cancer Center (1)
Canada (2) · United States (1)
Annie Huang (1) · Dr. Helene Flageole, MD, FRCSC (1) · Lucie Lafay-Cousin (1) · Mark B Geyer, MD (1) · Sylvia Cheng (1)